Allogene Therapeutics (ALLO) Debt US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
Debt, bln rub 51.3 53.8 69.9 95.1 95.1   85.1  
Changes by years, y/y, % +49% +5% +30% +36% 0%     +22.5%

Allogene Therapeutics. Debt, bln rub

Allogene Therapeutics. Debt, changes, %

Allogene Therapeutics (ALLO) Debt US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Debt, bln rub 90.1 95.1 95.8 94.2 85.1   85.1
Changes by years, y/y, % -7% 0% -4% +3% -6%    
Changes by quarters, q/q, % -2% +6% +1% -2% -10%    

Allogene Therapeutics. Debt, bln rub

Allogene Therapeutics. Debt, changes, y/y, %

Allogene Therapeutics. Debt, changes, q/q, %